Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rohrberg

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2012
Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemiaT Steinmetz, B Tschechne, O Harlin, et al.
Cancer Treatment Reviews|November 7, 2006
Bisphosphonate-related jaw necrosis--severe complication in maxillofacial surgeryA W Eckert, P Maurer, L Meyer, et al.
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|October 1, 1986
[Clinical aspects and prognosis of highly malignant non-Hodgkin's lymphomas]R Rohrberg, K Krug, D Krahl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb studyB Schultheis, D Reuter, M P Ebert, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2012
Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemiaT Steinmetz, B Tschechne, O Harlin, et al.
Cancer Treatment Reviews|November 7, 2006
Bisphosphonate-related jaw necrosis--severe complication in maxillofacial surgeryA W Eckert, P Maurer, L Meyer, et al.
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|October 1, 1986
[Clinical aspects and prognosis of highly malignant non-Hodgkin's lymphomas]R Rohrberg, K Krug, D Krahl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb studyB Schultheis, D Reuter, M P Ebert, et al.
Pageof 2